1,031 research outputs found

    Multicharged Dyonic Integrable Models

    Get PDF
    We introduce and study new integrable models of A_n^{(1)}-Non-Abelian Toda type which admit U(1)\otimes U(1) charged topological solitons. They correspond to the symmetry breaking SU(n+1) \to SU(2)\otimes SU(2)\otimes U(1)^{n-2} and are conjectured to describe charged dyonic domain walls of N=1 SU(n+1) SUSY gauge theory in large n limit. It is shown that this family of relativistic IMs corresponds to the first negative grade q={-1} member of a dyonic hierarchy of generalized cKP type. The explicit relation between the 1-soliton solutions (and the conserved charges as well) of the IMs of grades q=-1 and q=2 is found. The properties of the IMs corresponding to more general symmetry breaking SU(n+1) \to SU(2)^{\otimes p}\otimes U(1)^{n-p} as well as IM with global SU(2) symmetries are discussed.Comment: 48pages, latex, v2. typos in eqns. (1.7) and (3.20) corrected, small improvements in subsection 2.2, new reference added;v3. improvements in text of Sect. 1,2 and 6; new Sect 7 and new refs. added; version to appear in Nucl. Phys.

    Sub-terahertz, microwaves and high energy emissions during the December 6, 2006 flare, at 18:40 UT

    Full text link
    The presence of a solar burst spectral component with flux density increasing with frequency in the sub-terahertz range, spectrally separated from the well-known microwave spectral component, bring new possibilities to explore the flaring physical processes, both observational and theoretical. The solar event of 6 December 2006, starting at about 18:30 UT, exhibited a particularly well-defined double spectral structure, with the sub-THz spectral component detected at 212 and 405 GHz by SST and microwaves (1-18 GHz) observed by the Owens Valley Solar Array (OVSA). Emissions obtained by instruments in satellites are discussed with emphasis to ultra-violet (UV) obtained by the Transition Region And Coronal Explorer (TRACE), soft X-rays from the Geostationary Operational Environmental Satellites (GOES) and X- and gamma-rays from the Ramaty High Energy Solar Spectroscopic Imager (RHESSI). The sub-THz impulsive component had its closer temporal counterpart only in the higher energy X- and gamma-rays ranges. The spatial positions of the centers of emission at 212 GHz for the first flux enhancement were clearly displaced by more than one arc-minute from positions at the following phases. The observed sub-THz fluxes and burst source plasma parameters were found difficult to be reconciled to a purely thermal emission component. We discuss possible mechanisms to explain the double spectral components at microwaves and in the THz ranges.Comment: Accepted version for publication in Solar Physic

    Study of ATLAS sensitivity to FCNC top decays

    Get PDF
    The ATLAS experiment sensitivity to top quark Flavour Changing Neutral Current (FCNC) decays was studied at LHC using ttbar events. While one of the top quarks is expected to follow the dominant Standard Model decay t->bW, the other decays through a FCNC channel, i.e. t-> Z u(c), t-> gamma u(c) or t-> g u(c). Different types of analyses, applied to each FCNC decay mode, were compared. The FCNC branching ratio sensitivity (assuming a 5sigma signal significance) and 95% confidence level limits on the branching ratios (in the hypothesis of signal absence) were obtained

    Cooling down the world oceans and the earth by enhancing the North Atlantic Ocean current

    Get PDF
    The world is going through intensive changes due to global warming. It is well known that the reduction in ice cover in the Arctic Ocean further contributes to increasing the atmospheric Arctic temperature due to the reduction of the albedo effect and increase in heat absorbed by the ocean’s surface. The Arctic ice cover also works like an insulation sheet, keeping the heat in the ocean from dissipating into the cold Arctic atmosphere. Increasing the salinity of the Arctic Ocean surface would allow the warmer and less salty North Atlantic Ocean current to flow on the surface of the Arctic Ocean considerably increasing the temperature of the Arctic atmosphere and release the ocean heat trapped under the ice. This paper argues that if the North Atlantic Ocean current could maintain the Arctic Ocean ice-free during the winter, the longwave radiation heat loss into space would be larger than the increase in heat absorption due to the albedo effect. This paper presents details of the fundamentals of the Arctic Ocean circulation and presents three possible approaches for increasing the salinity of the surface water of the Arctic Ocean. It then discusses that increasing the salinity of the Arctic Ocean would warm the atmosphere of the Arctic region, but cool down the oceans and possibly the Earth. However, it might take thousands of years for the effects of cooling the oceans to cool the global average atmospheric temperature

    Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study

    Full text link
    Purpose: Pembrolizumab and pembrolizumab-chemotherapy demonstrated efficacy in recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048. Post hoc analysis of long-term efficacy and progression-free survival on next-line therapy (PFS2) is presented. Methods: Patients were randomly assigned (1:1:1) to pembrolizumab, pembrolizumab-chemotherapy, or cetuximab-chemotherapy. Efficacy was evaluated in programmed death ligand 1 (PD-L1) combined positive score (CPS) ≥ 20, CPS ≥ 1, and total populations, with no multiplicity or alpha adjustment. Results: The median study follow-up was 45.0 months (interquartile range, 41.0-49.2; n = 882). At data cutoff (February 18, 2020), overall survival improved with pembrolizumab in the PD-L1 CPS ≥ 20 (hazard ratio [HR], 0.61; 95% CI, 0.46 to 0.81) and CPS ≥ 1 populations (HR, 0.74; 95% CI, 0.61 to 0.89) and was noninferior in the total population (HR, 0.81; 95% CI, 0.68 to 0.97). Overall survival improved with pembrolizumab-chemotherapy in the PD-L1 CPS ≥ 20 (HR, 0.62; 95% CI, 0.46 to 0.84), CPS ≥ 1 (HR, 0.64; 95% CI, 0.53 to 0.78), and total (HR, 0.71; 95% CI, 0.59 to 0.85) populations. The objective response rate on second-course pembrolizumab was 27.3% (3 of 11). PFS2 improved with pembrolizumab in the PD-L1 CPS ≥ 20 (HR, 0.64; 95% CI, 0.48 to 0.84) and CPS ≥ 1 (HR, 0.79; 95% CI, 0.66 to 0.95) populations and with pembrolizumab-chemotherapy in the PD-L1 CPS ≥ 20 (HR, 0.64; 95% CI, 0.48 to 0.86), CPS ≥ 1 (HR, 0.66; 95% CI, 0.55 to 0.81), and total (HR, 0.73; 95% CI, 0.61 to 0.88) populations. PFS2 was similar after pembrolizumab and longer after pembrolizumab-chemotherapy on next-line taxanes and shorter after pembrolizumab and similar after pembrolizumab-chemotherapy on next-line nontaxanes. Conclusion: With a 4-year follow-up, first-line pembrolizumab and pembrolizumab-chemotherapy continued to demonstrate survival benefit versus cetuximab-chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma. Patients responded well to subsequent treatment after pembrolizumab-based therapy
    corecore